Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Diagnostic test for predicting metastasis and recurrence in cutaneous melanoma

Diagnostic test for predicting metastasis and recurrence in cutaneous melanoma

US Patent 10577660 · Granted Mar 3, 2020

Estimated economic value: $11,229,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diagnostic test for predicting metastasis and recurrence in cutaneous melanoma2025
Diagnostic test for predicting metastasis and recurrence in cutaneous melanoma2025
Diagnostic test for predicting metastasis and recurrence in cutaneous melanoma2025
Methods of diagnosing and treating patients with cutaneous squamous cell carcino2024
Methods of diagnosing and treating patients with cutaneous squamous cell carcino2024
Methods of diagnosing and treating patients with cutaneous squamous cell carcino2024
Methods of diagnosing and treating patients with cutaneous squamous cell carcino2024
Diagnostic test for predicting metastasis and recurrence in cutaneous melanoma2022
Diagnostic test for predicting metastasis and recurrence in cutaneous melanoma2022
Diagnostic test for predicting metastasis and recurrence in cutaneous melanoma2022
Compositions for and methods of detecting, diagnosing, and prognosing thymic can2019
Compositions for and methods of detecting, diagnosing, and prognosing thymic can2019